ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Dalacin C 300 mg, Hartkapseln - 16 Kapsel(n)
35438076 Pfizer AG
Dalacin C 300 mg, Hartkapseln18.12.1970
Original22.08.2006
Clindamycin (J01FF01)22.08.2006
WHO-DDD 
08.01.92.16 Kapsel(n)
08.01.92. 
A  
Yes 
IPCI
12.93No
    
10 %27.15
7680354380763Synthetika
879328 
Composition
clindamycinum 300 mg ut clindamycini hydrochloridum, maydis amylum, talcum, magnesii stearas, lactosum monohydricum max. 283.27 mg, Kapselhülle: gelatina, E 171, Drucktinte: lacca, E 172 (nigrum), propylenglycolum, ammoniae solutio concentrata, kalii hydroxidum, pro capsula.
Teilbarkeit
 -- 
 Ja 
 -- 
 Ja 
 Bitterer Geschmack. Alternative: Dalacin C Granulat zur Herstellung einer Suspension (Rezept) 
 
 
th_part
Capsules 
 
Active AgentDose
Clindamycin300 mg
BAG: Active AgentDose
Clindamycin300 mg
 
Inactive agentsDoseadditional_information
(Nigrum)  
Ammoniae Solutio Concentrata  
E 171 color.
E 172 color.
Gelatina Kapselhülle
Kalii Hydroxidum  
Lacca Drucktinte
Lactose Monohydrate283.27 mg 
Magnesii Stearas  
Maydis Amylum  
Pro Capsula  
Propylenglycol  
Talcum  
 
Source
Data was imported : 12.05.2021 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2024 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home